open access

Vol 94, No 11 (2023)
Research paper
Published online: 2023-02-03
Get Citation

Prospective analysis of the impact of adjuvant treatment with external beam radiation therapy and vaginal brachytherapy on health-related quality of life in patients with early-stage endometrioid endometrial carcinoma

Adam Kluska1, Bartlomiej Tomasik2, Malgorzata Moszynska-Zielinska3, Leszek Zytko3, Natalia Tracz4, Michal Spych5, Jacek Fijuth53, Leszek Gottwald53
·
Pubmed: 36929785
·
Ginekol Pol 2023;94(11):867-873.
Affiliations
  1. Brachytherapy Department, Greater Poland Cancer Centre, Poznan, Poland
  2. Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland
  3. Department of Teleradiotherapy, Regional Cancer Centre, Copernicus Memorial Hospital of Lodz, Poland
  4. Department of Radiotherapy and Oncological Gynecology, Greater Poland Cancer Center, Poznan, Poland
  5. Department of Radiotherapy, Chair of Oncology, Medical University of Lodz, Poland

open access

Vol 94, No 11 (2023)
ORIGINAL PAPERS Gynecology
Published online: 2023-02-03

Abstract

Objectives: Our study evaluates the impact of adjuvant treatment with external beam radiotherapy (EBRT) combined with vaginal high dose rate brachytherapy (HDR BT) on health related quality of life (HRQL) in patients with early stage endometrioid endometrial carcinoma.

Material and methods: From March 2019 to February 2021, 60 patients were enrolled with early stage endometrioid endometrial carcinoma, and qualified to adjuvant treatment after hysterectomy. HRQL was assessed using the EORTC QLQ-C30 questionnaire, with the endometrial cancer-specific HRQL module EORTC QLQ-EN24. Questionnaires were completed in four timepoints during adjuvant radiotherapy.

Results: A significant decrease in mean global health status / quality of life (p < 0.001) and role functioning (p = 0.028) was noted, as assessed in EORTC QLQ-C30 scale. Among the EORTC QLQ-C30 symptoms scales, significant differences were noted in the fatigue scale (p = 0.003), pain scale (p = 0.001), constipation scale (p < 0.001) and diarrhea scale (p < 0.001) over time. The EORTC QRQ-EN24 analysis showed significant deterioration in the urological symptoms scale (p < 0.001), gastrointestinal symptoms scale (p < 0.001) and in the mean pain in back and pelvis scale (p = 0.003).

Conclusions: Adjuvant radiotherapy in patients with early-stage endometrioid endometrial cancer after hysterectomy is associated with worse quality of life, especially due to the toxicity of the treatment in relation to the gastrointestinal tract and urinary system.

Abstract

Objectives: Our study evaluates the impact of adjuvant treatment with external beam radiotherapy (EBRT) combined with vaginal high dose rate brachytherapy (HDR BT) on health related quality of life (HRQL) in patients with early stage endometrioid endometrial carcinoma.

Material and methods: From March 2019 to February 2021, 60 patients were enrolled with early stage endometrioid endometrial carcinoma, and qualified to adjuvant treatment after hysterectomy. HRQL was assessed using the EORTC QLQ-C30 questionnaire, with the endometrial cancer-specific HRQL module EORTC QLQ-EN24. Questionnaires were completed in four timepoints during adjuvant radiotherapy.

Results: A significant decrease in mean global health status / quality of life (p < 0.001) and role functioning (p = 0.028) was noted, as assessed in EORTC QLQ-C30 scale. Among the EORTC QLQ-C30 symptoms scales, significant differences were noted in the fatigue scale (p = 0.003), pain scale (p = 0.001), constipation scale (p < 0.001) and diarrhea scale (p < 0.001) over time. The EORTC QRQ-EN24 analysis showed significant deterioration in the urological symptoms scale (p < 0.001), gastrointestinal symptoms scale (p < 0.001) and in the mean pain in back and pelvis scale (p = 0.003).

Conclusions: Adjuvant radiotherapy in patients with early-stage endometrioid endometrial cancer after hysterectomy is associated with worse quality of life, especially due to the toxicity of the treatment in relation to the gastrointestinal tract and urinary system.

Get Citation

Keywords

endometrial carcinoma; radiotherapy; brachytherapy; quality of life

About this article
Title

Prospective analysis of the impact of adjuvant treatment with external beam radiation therapy and vaginal brachytherapy on health-related quality of life in patients with early-stage endometrioid endometrial carcinoma

Journal

Ginekologia Polska

Issue

Vol 94, No 11 (2023)

Article type

Research paper

Pages

867-873

Published online

2023-02-03

Page views

385

Article views/downloads

309

DOI

10.5603/GP.a2023.0007

Pubmed

36929785

Bibliographic record

Ginekol Pol 2023;94(11):867-873.

Keywords

endometrial carcinoma
radiotherapy
brachytherapy
quality of life

Authors

Adam Kluska
Bartlomiej Tomasik
Malgorzata Moszynska-Zielinska
Leszek Zytko
Natalia Tracz
Michal Spych
Jacek Fijuth
Leszek Gottwald

References (24)
  1. Department of Epidemiology and Cancer Prevention, Polish National Cancer Registry. Cancer in Poland in 2016. http://www.onkologia.org.pl.
  2. Didkowska J, Wojciechowska U. Epidemiology of the genital malignancies in the female in Poland. Curr Opin Oncol. 2012; 10: 25–37.
  3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1): 10–17.
  4. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol. 2004; 11(3): 117–142.
  5. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2001; 15(3): 341–354.
  6. Braun MM, Overbeek-Wager EA, et al. Diagnosis and Management of Endometrial Cancer. Am Fam Physician. 2016; 93: 468–474.
  7. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(1): 16–41.
  8. Gadducci A, Cavazzana A, Cosio S, et al. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer. Anticancer Res. 2009; 29(5): 1715–1720.
  9. Leppert W, Gottwald L, Forycka M. Clinical practice recommendations for quality of life assessment in patients with gynecological cancer. Prz Menopauzalny. 2015; 14(4): 271–282.
  10. Jitender S, Mahajan R, Rathore V, et al. Quality of life of cancer patients. J Exp Ther Oncol. 2018; 12(3): 217–221.
  11. Fayers P, Bottomley A. EORTC Quality of Life Group, Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002; 38 Suppl 4: S125–S133.
  12. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5): 365–376.
  13. Greimel E, Nordin A, Lanceley A, et al. EORTC Quality of Life Group. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer. 2011; 47(2): 183–190.
  14. Salehi S, Brandberg Y, Åvall-Lundqvist E, et al. Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer - results from the RASHEC trial. Acta Oncol. 2018; 57(12): 1671–1676.
  15. Nama V, Patel A, Kirk L, et al. Role of Systematic Lymphadenectomy to Tailor Adjuvant Therapy in Early Endometrial Cancer. Int J Gynecol Cancer. 2018; 28(1): 107–113.
  16. Stanic S, Mayadev JS. Tolerance of the small bowel to therapeutic irradiation: a focus on late toxicity in patients receiving para-aortic nodal irradiation for gynecologic malignancies. Int J Gynecol Cancer. 2013; 23(4): 592–597.
  17. Nout RA, Putter H, Jürgenliemk-Schulz IM, et al. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer. 2012; 48(11): 1638–1648.
  18. Boer Sde, Powell M, Mileshkin L, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2018; 19(3): 295–309.
  19. Jereczek-Fossa BA, Badzio A, Jassem J. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol. 2003; 68(1): 33–39.
  20. Robertson MC, Lyons EJ, Song J, et al. Change in physical activity and quality of life in endometrial cancer survivors receiving a physical activity intervention. Health Qual Life Outcomes. 2019; 17(1): 91.
  21. Velikova G, Williams LJ, Willis S, et al. MRC SUPREMO trial UK investigators. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol. 2018; 19(11): 1516–1529.
  22. Creutzberg CL, Nout RA, Lybeert MLM, et al. PORTEC Study Group. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011; 29(13): 1692–1700.
  23. Nock NL, Dimitropoulos A, Zanotti KM, et al. Sleep, quality of life, and depression in endometrial cancer survivors with obesity seeking weight loss. Support Care Cancer. 2020; 28(5): 2311–2319.
  24. Foerster R, Schnetzke L, Bruckner T, et al. Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer. Strahlenther Onkol. 2016; 192(12): 895–904.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl